Main Content

Al Rojo Vivo

FDA respalda la efectividad de la vacuna de Johnson & Johnson contra el COVID-19

Also available on the nbc app

La FDA determinó que la vacuna de Johnson & Johnson contra el COVID-19, que solo requiere una dosis, es 72% efectiva y podría estar cerca de aprobarla.

Tags: Telemundo, johnson and johnson, vacuna, Covid, coronavirus, FDA, estados unidos
S2021 E01 minHighlightNews and InformationDaytime
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences. By using the site, you consent to these cookies. For more information on cookies including how to manage your consent visit our cookie policy.